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The cell-intrinsic mechanisms guiding naive CD8+
T cells for clonal expansion and memory generation
via homeostatic proliferation (HP) are unclear. Here,
we have shown that HP of naive CD8+ T cells requires
IL-7-, but not IL-15-induced mTOR kinase activation.
HP-induced mTOR enhances transcription factor
T-bet for functional maturation and CD122 expres-
sion, which sensitizes for an IL-15-dependent
memory transition by favoring transcription factor
Eomesodermin over T-bet. Inhibition of mTOR
blocks T-bet and CD122 expression but preserves
memory in an IL-15-independent manner by pro-
moting Eomesodermin expression. The ability of
rapamycin to augment HP-induced memory was
cell-intrinsic given that silencing mTOR in CD8+
T cells generated identical outcomes. Strikingly,
HP-induced CD8+ T cell memory generated by IL-15-
dependent or -independent mechanisms demon-
strated identical tumor efficacy. These results indi-
cate a central role for mTOR in HP-induced CD8+
T cell responses and demonstrate the importance
for CD8+ memory in HP-induced tumor efficacy.
INTRODUCTION
The stimulation of naive CD8+ T cells with antigen, costimulation,
and cytokines induce vigorous proliferation and associated
differentiation that can give rise to various effector and/or
memory phenotypes (Ahmed and Gray, 1996). Alternatively,
naive CD8+ T cells can undergo proliferation in the absence of
antigen, in response to space (self-antigen-MHC, cytokines
like interleukin-7 [IL-7], and/or IL-15) secondary to lymphopenia
(genetic deficiency, infection, irradiation, or unprimed neonatal
animals) (Ernst et al., 1999; Goldrath and Bevan, 1999; Kieper
and Jameson, 1999; Le Campion et al., 2002). The antigen-inde-
pendent proliferation exhibited by naive CD8+ T cells has been
termed as homeostatic proliferation (HP), and it plays an impor-
tant role in maintaining normal CD8+ T cell numbers (Cho et al.,2000; Ernst et al., 1999; Goldrath and Bevan, 1999; Kieper and
Jameson, 1999; Murali-Krishna et al., 1999). Additionally, lym-
phopenia-induced proliferation of naive CD8+ T cells induces
functional maturation resulting in suboptimal effector functions
(IFN-g and/or cytolytic T lymphocyte [CTL] activity) and transition
to memory-like cells (Goldrath et al., 2000; Hamilton et al., 2006;
Surh and Sprent, 2008).
The critical role of extrinsic cues like self-antigen-MHC class I
and IL-7 in HP of CD8+ T cells has been demonstrated (Ernst
et al., 1999; Goldrath and Bevan, 1999; Tan et al., 2001). It is en-
visioned that weak but frequent T cell receptor (TCR) interactions
with abundant self-peptide-MHC class I molecules and IL-7
under conditions of lymphopenia induces cell cycling and HP
of naive CD8+ T cells (Li et al., 2006; Schluns et al., 2000; Tan
et al., 2001). Although, the other common g-chain (gc) cytokine,
IL-15, has also been implicated in HP of naive CD8+ T cells, it was
unable to compensate for IL-7 deficiency in HP of naive CD8+
T cells (Tan et al., 2001). However, IL-15 is important for
sustained CD8+ T cell proliferation and accumulation in a lym-
phopenic setting (Sandau et al., 2007), and the reduction in
HP-induced CD8+ T cells expressing CD62L and CD44hi pheno-
type in IL-15Ra-deficient mice indicates the need for IL-15 in
promoting CD8+ T cell memory but not initiation of HP (Kennedy
et al., 2000; Lodolce et al., 1998; Ramsey et al., 2008). Together,
the gc cytokines IL-7 and IL-15 act in concert to maintain CD8+
T cell homeostasis, but their precise mechanisms of action and
collaboration are not completely understood.
The binding of IL-7 to IL-7Ra on naive CD8+ T cells can initiate
a signaling cascade that leads to phosphorylation of signal trans-
ducers and activators of transcription 5 (STAT5) and the kinase
cascades involving phosphatidylinositol 3-kinase (PI3K)-protein
kinase B (PKB, also called Akt) andmammalian target of rapamy-
cin (mTOR) for preventing naive T cell atrophy (Plas et al., 2001;
Rathmell et al., 2001; Wofford et al., 2008). The ability of IL-7 to
induce these pathways suggests a role for IL-7 in regulating
CD8+ T cell survival and growth during lymphopenia-induced
HP. The fact that activated CD8+ T cells upregulate CD122
(IL-2 receptor b chain), the signaling component of the IL-15R
complex, provides an explanation for the reliance on IL-15 for
memory CD8+ T cell generation (Intlekofer et al., 2005; Judge
et al., 2002; Ku et al., 2000). However, CD122 is a direct gene
target of the transcription factor T-bet, whose expression has
been inversely correlated with CD8+ T cell memory generationImmunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc. 541
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mTOR Programs HP-Induced CD8+ T Cell Responses(Intlekofer et al., 2005; Joshi et al., 2007; Matsuda et al., 2007). It
is reasonable to suggest that IL-15 rescues effector cells for
memory; yet this notion has not been formally tested, particularly
in HP-induced generation of CD8+ T cell memory.
Although the antigen stimulated and HP-induced CD8+ T cells
seem to undergo proliferation, clonal expansion, and functional
maturation for memory (Haluszczak et al., 2009; Hamilton
et al., 2006; Suzuki et al., 2008), several distinctions have been
noted. The early activation markers typically associated with
antigen-stimulated CD8+ T cells are not observed with HP-
induced stimulation, and the HP-induced functional maturation
is weaker and transient. In addition, HP-induced CD8+ T cells
display higher CD44 and CD122, and also retain expression of
CD62L (Goldrath et al., 2000; Murali-Krishna et al., 1999). The
HP-induced memory cells display weaker ability to mount
antigen-recall responses and are therefore considered to be
less potent than antigen-induced memory cells (Cheung et al.,
2009). Nevertheless, HP-induced CD8+ T cell responses have
been shown to impart considerable efficacy against infectious
and tumor challenge (Dummer et al., 2002; Hamilton et al., 2006).
Recent evidence demonstrates an essential role for mTOR in
memory CD8+ T cell differentiation. Rapamycin treatment of
lymphocytic choriomeningitis virus (LCMV)-infected mice was
shown to increase the quantity and quality of memory CD8+
T cells in a T cell-intrinsic manner (Araki et al., 2009). We have
further demonstrated the ability of mTOR to instruct effector
versus memory cell fate of antigen-specific CD8+ T cells by
regulating the expression of transcription factors T-bet and
Eomesodermin (Eomes) (Rao et al., 2010). However, its role in
integrating self-MHC and cytokine signals (IL-7 and/or IL-15) to
regulate lymphopenia-induced homeostatic proliferation, func-
tional maturation, and memory function has not been reported.
The increasing use of bone marrow transplantation (BMT),
radiation, and chemotherapy behooves us to better understand
the cell-intrinsic mechanisms that regulate HP-induced CD8+
T cell clonal expansion and memory. In this study, we present
the evidence for a central role of mTOR in bridging IL-7 and
IL-15 mediated HP-induced CD8+ clonal expansion, memory
functions, and tumor efficacy. This understanding will enable
new approaches to harness homeostatic proliferation for immu-
nity and restrict self-reactivity.
RESULTS
HP Induced CD8+ T Cell Clonal Expansion and
Functional Maturation Is IL-7 but Not IL-15 Dependent
The homeostatic cytokines IL-7 and IL-15 play a crucial role in
lymphopenia-induced HP that restores CD8+ T cell numbers
and promotes memory generation (Surh and Sprent, 2008;
Takada and Jameson, 2009). To explore potential contributions
of these cytokines in regulating HP-induced CD8+ T cell prolifer-
ation, expansion, and functional maturation, we monitored
carboxy fluorescein diacetate succinimidyl ester (CFSE)-labeled
naive OT-1 cells after adoptive transfer into irradiated B6, B6
Il15/ or B6 mice treated with anti-IL-7Ra. Consistent with
previous findings, we demonstrated that IL-7 blockade consid-
erably reduced lymphopenia induced OT-1 proliferation and
clonal expansion on day 5 (Figure 1A). Interestingly, IL-15-defi-
cient (B6 Il15/) recipients showed no reduction in OT-1 prolif-542 Immunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc.eration or expansion (Figure 1B). Furthermore, the OT-1 cells
transferred to recipients with IL-7 blockade failed to undergo
functional maturation (IFN-g and granzyme-B production) (Fig-
ure 1A), but no difference in OT-1 functional maturation was
observed in Il15/ recipients (Figure 1B). To confirm our
in vivo observations and demonstrate the sufficiency of IL-7 to
induce proliferation (CFSE), clonal expansion, and functional
maturation of naive CD8+ T cells, we tested the addition of IL-7
to OT-1 cells in an in vitro system. As shown in Figure 1C, IL-7
was sufficient for inducing OT-1 proliferation and functional
maturation by day 5 (Figure 1C and data not shown). In addition,
IL-7 but not IL-15 at the concentration of 10 ng/ml induced cell
proliferation and IFN-g production, which was almost identical
for TCR transgenic (Tg) CD8+ T cells (OT-1) or polyclonal CD8+
T cells from B6 mice (Figure S1A available online). These results
establish an essential role for IL-7 in the initiation of lymphope-
nia-induced naive CD8+ T cell proliferation for functional matura-
tion. In addition, the extent of lymphopenia caused by radiation
dosage regulated CD8+ T cell clonal expansion and functional
maturation given that CFSE-labeled naive OT-1 Thy1.1+ cells
that were transferred into mice irradiated with 0, 175, and
700 rad showed dose-dependent increases in CFSE dilution,
cell number, and functional maturation (IFN-g and in vivo CTL)
(Figure S1B).
IL-7 Induces mTOR to Promote HP-Induced Clonal
Expansion and Functional Maturation of CD8+ T Cells
The energy-sensitive kinase mTOR has been shown to regulate
memory generation in antigen-stimulated CD8+ T cells (Araki
et al., 2009; Rao et al., 2010). Because HP-induced functional
maturation results in CD8+ T cell memory, we explored the
potential role for mTOR kinase in lymphopenia-associated
CD8+ T cell response by testing the ability of HP to induce
mTOR activity, by evaluating the phosphorylation of its down-
stream target, ribosomal protein S6 (pS6), as a functional
readout of mTOR activity (Burnett et al., 1998). As shown in
Figure 2A, HP dramatically induced mTOR activity (pS6) in
OT-1 cells, which was blocked by anti-IL-7Ra treatment (Fig-
ure 2B). In agreement, the addition of IL-7 but not IL-15 to naive
OT-1 cells in vitro induced a dose-dependent (1 or 10 ng/ml)
increase of mTOR phosphorylation (mTORp) and pS6 (Figures
S2A and S2B). These results demonstrate that HP induces an
IL-7-dependent increase in mTOR activity, which may play a
potential role in regulating CD8+ T cell homeostasis under condi-
tions of lymphopenia.
We next inquired whether rapamycin, a specific inhibitor of
mTORcomplex-1, couldblockHP-inducedCD8+Tcell responses.
Administrationof rapamycin fromday0–7 (750mg/kg/day) blocked
lymphopenia-induced mTORp and pS6 in OT-1 cells (Figure 2C)
and concomitantly decreased proliferation and clonal expansion
(Figures 2D and 2E). The relatively high dose of rapamycin
(750 mg/kg/day) has been previously used in vivo to block
Graft-versus-host diseases (GVHDs) (Blazar et al., 1998) and
was found to be optimum in a titration study for blocking mTOR
in OT-1 cells in vivo (data not shown). Notably, the lymphopenia
induced IL-7-dependent increases inOT-1 functionalmaturation;
IFN-g, granzyme-B production, and in vivo CTL activity was
reduced upon mTOR inhibition (Figures 2F and 2G). This was
further corroborated by the loss of IL-7 induced mTOR activity,
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Figure 1. Lymphopenia-Induced CD8+ T Cell HP and Functional Maturation Is IL-7 but Not IL-15 Dependent
(A) CFSE-labeled naive OT-1 cells (13 106) were transferred into intact or irradiated (700 rads) syngeneic recipients on day 0. Some radiated recipients received
either an isotype control (700 rad) or anti-IL-7Ra (100 mg per mouse, 700 rad+anti-IL-7Ra) on day 1 and day 2. The CD8a+Thy1.1+ cells were gated and
evaluated by flow cytometric analysis of recipient spleens on day 5 for proliferation-CFSE dilution (left), the clonal expansion-absolute number of OT-1 cells
(middle) (as described in Experimental Procedures), and effector functions IFN-g and Granzyme B (Gzm B) expression detected by ICS (right).
(B) The day 5 response of CFSE-labeled naive OT-1 cells in intact or irradiated syngeneic B6 or Il15/ recipients were evaluated by flow cytometry for
proliferation-CFSE dilution (left), absolute numbers of OT-1 cells (middle), and the expression of IFN-g and Gzm B (right).
(C) In vitro CFSE-labeled naive OT-1 cells cultured with IL-7 (10 ng/ml), IL-15 (10 ng/ml), or medium were analyzed for proliferation-CFSE dilution (left), cell
recovery (middle), and the expression of IFN-g and Gzm B (right) at 120 hr. The bars represent SD of three individual samples and the results shown are
representative of three independent experiments with similar outcomes (*p < 0.05; ***p < 0.001).
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mTOR Programs HP-Induced CD8+ T Cell Responsesproliferation, clonal expansion, and functionalmaturation ofOT-1
cells upon rapamycin treatment in vitro (Figures S2C and S2D).
Interestingly, the IL-7-induced mTOR activity (pS6) was PI3K
dependent (Figure S2E), supporting the previously noted obser-
vation that IL-7-induced CD8+ T cell responses are PI3K depen-
dent. These observations indicate an essential role for IL-7
inducedmTOR for regulating HP-induced CD8+ T cell expansion
and functional maturation.
HP Promotes mTOR-Dependent T-bet Expression
for CD8+ T Cell Functional Maturation
The acquisition of type I effector functions in antigen-experi-
enced CD8+ T cells is governed by the master regulatory tran-
scription factor T-bet (Szabo et al., 2000). To test the notion
that T-bet plays a role in IL-7-dependent HP-induced CD8+
T cell functional maturation, we transferred CFSE-labeled naive
OT-1 cells into irradiated recipients and evaluated the ability of
HP to induce T-bet expression in OT-1 cells on day 5 after
transfer. As predicted, HP induced T-bet expression, which cor-
responded with the extent of OT-1 cell proliferation (Figure 3A).
Moreover, the increase in T-bet was accompanied by an
increase in CD122 expression (Figure 3A), which required IL-7in vivo, given that anti-IL-7Ra abrogated the increase in T-bet
and CD122 expression (Figure 3B). These results demonstrate
an essential role for T-bet in HP-induced CD8+ T cell responses
and CD122 expression.
To characterize the role of mTOR-T-bet-CD122 pathway in
HP-induced CD8+ T cell functional maturation, we evaluated
T-bet and CD122 expression on OT-1 cells in rapamycin-treated
recipients. Clearly, rapamycin treatment blockedmTOR induced
T-bet and subsequent CD122 expression (Figure 3C), which was
confirmed by our in vitro observations (Figure S3A). By in vivo
monitoring, we compared HP-induced CD8+ clonal expansion,
functional maturation, and CD122 expression by WT and
Tbx21/ (T-bet/) OT-1 Thy1.1+ cells on day 5. The T-bet
deficiency reduced CD122 expression (Figure 3D), but not prolif-
eration (Figure 3E) or OT-1 cell numbers (Figure 3F). Notably in
the absence of T-bet, HP-induced functional maturation was
diminished as reflected by IFN-g production and in vivo CTL
activity (Figure 3F). Surprisingly, the Tbx21/OT-1 cells showed
similar cell surface phenotype (day 5; CD44, CD62L, IL-7Ra,
IL-15Ra, and KLRG1) except for reduced CD122 expression
(Figures S3B and S3D). These results identify a previously unap-







Figure 2. IL-7 Induced mTOR Activity Is Essential for HP-Induced Functional Maturation of CD8+ T Cells
(A and B) OT-1 cells detected in the spleens of recipients receiving different doses of irradiation, 0, 175, or 700 rads (A), or 700 rads irradiation followed by
anti-IL-7Ra (100 mg) on day 1 and day 2 (B) were evaluated for phosphorylation of S6 by ICS and flow cytomtery.
(C–F) OT-1 detected in recipients treated with 700 rad or 700 rad plus a daily injection of rapamycin (0.75 mg/kg/day) from day 0–4 were evaluated on day 5 for
phosphorylation of mTOR and S6 (C), CFSE dilution (D), absolute numbers of OT-1 cells (E), and IFN-g and Granzyme B expression by ICS and flow cytometry (F).
(G) In vivo CTL activity produced by normalized numbers of OT-1 cells, the percentage of specific lysis is indicated above histograms. The error bars represent the
SD of three independently obtained values. A representative of three experiments with identical restults is shown (**p < 0.01).
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mTOR Programs HP-Induced CD8+ T Cell Responsesmaturation and CD122 expression and suggest a potential role
for mTOR kinase in bridging IL-7 and IL-15 mediated CD8+
T cell homeostasis.
T-bet Programs IL-15 Dependent HP-Induced Memory
CD8+ T Cells
The fact that T-bet is essential for CD122 expression (Figure 3D)
and IL-15 is important for CD8+ T cell accumulation during HP
(Sandau et al., 2007), suggests a pivotal role for mTOR in inte-
grating IL-7 and IL-15 signals to regulate HP-induced CD8+
T cell memory. To test this possibility, we adoptively transferred544 Immunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc.naivewild-type (WT) or Tbx21/OT-1 Thy1.1+ cells into intact or
irradiated B6 recipients andmonitored their persistence (day 40),
and the ability to mount antigen recall-responses (day 43), as a
measure of memory function. In comparison to Tbx21/ OT-1
cells, the WT OT-1 cells underwent significant clonal expansion,
persisted up to day 40 (Figure 4A), and produced a considerable
antigen-recall response; clonal expansion and effector func-
tions, after re-challenge (Figure 4B). In contrast, the Tbx21/
OT-1 cells failed to persist in irradiated B6 recipients (Figure 4A)
and subsequently produced poor antigen-recall responses




Figure 3. HP-IL-7 Induced mTOR Activity Is Essential for T-bet-Mediated Functional Maturation
(A–F) Naive WT or Tbx21/ OT-1 cells were detected by flow cytometry on day 5 after transfer into intact or irradiated (700 rads) recipients that were either
untreated (A, D, E, and F) or treated with anti-IL-7Ra (100 mg) on day1 and day 2 (B) or treated with rapamycin (0.75 mg/kg/day) (C) and evaluated for (A) CFSE
dilution, T-bet, and CD122 expression.
(B and C) T-bet and CD122 expression in recipients treated with anti-IL-7Ra (B) or in radiated recipients treated with rapamycin (C).
(D) The expression of CD122 in WT or Tbx21/ OT-1 cells.
(E) CFSE dilution of WT or Tbx21/ OT-1 cells.
(F) The number of OT-1 (CD8a+Thy1.1+) cells (left), percentage of IFN-g+ OT-1 cells (middle), and the percentage of cells in vivo cytolysis (right). The error bars are
SD of three independently obtained values. The data shown is representative of three experiments (*p < 0.05; **p < 0.01; n.s., not significant).
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mTOR Programs HP-Induced CD8+ T Cell Responsesfor T-bet expression in HP-induced memory CD8+ T cell
responses and identify an important role for T-bet in CD8+
T cell persistence.
To determine whether T-bet mediates HP-induced CD8+ T cell
memory via IL-15, we transferred naive WT or Tbx21/ OT-1
cells into irradiated WT or Il15/ hosts and assessed their
persistence and antigen-recall responses at day 40 and 43.
Consistent with an earlier report demonstrating the belated
requirement for IL-15 in HP-induced CD8+ T cell responses
(Sandau et al., 2007),WTOT-1 cells transferred into Il15/ hosts
failed to persist up to day 40 and produce antigen-recall
responses (Figures 4A and 4B). Moreover, the absence of
T-bet in OT-1 cells and IL-15 in recipients further abrogated
the HP-induced CD8+ T cell response (in comparison to WT
recipients) (Figures 4A and 4B). These results demonstrate the
requirement of HP-IL-7-mTOR-induced T-bet expression for
CD8+ T cell memory via the cell-extrinsic factor IL-15. Theseobservations are further corroborated by our in vitro experi-
ments, in which IL-7 conditioned OT-1 cells underwent a dose-
dependent proliferation in response to IL-15 and this response
to IL-15 was T-bet dependent (Figure S4A). In addition, the cell
recovery of WT OT-1 cells in Il15/ hosts was equivalent to
the cell recovery of Tbx21/ OT-1 cells in WT hosts, reiterating
the interdependency of cell intrinsic regulation of CD122 expres-
sion by T-bet and cell extrinsic requirement for IL-15 in program-
ming HP-induced CD8+ T cell persistence for memory.
To confirm whether T-bet expression was involved with the
previously noted role for STAT5 in IL-15 mediated CD8+ T cell
homeostasis (Kelly et al., 2003), we evaluated STAT5 phosphor-
ylation (pSTAT5) in OT-1 cells treated with varying doses of IL-15
after conditioning with IL-7. The WT OT-1 cells showed an IL-15
dose-dependent increase in pSTAT5 after IL-7 pretreatment, and
such an increase was lost in Tbx21/ OT-1 cells (Figure S4B).
These results support the argument that HP-IL-7-inducedImmunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc. 545
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Figure 4. HP-Induced T-bet Augments IL-15-Dependent CD8+ T Cell Memory
(A) Naive WT or Tbx21/OT-1 cells transferred to radiated B6 or Il15/B6 recipients were evaluated for the absolute numbers of OT-1 (CD8a+Thy1.1+) cells on
day 40.
(B) OT-1 cell numbers (3 days after rechallenge, day 43) (left), the percentage of IFN-g+ OT-1 cells (middle), and in vivo cytolysis (right). Numbers in parenthesis
(left panel) is the OT-1 fold increase. The error bars represent SD of values from three mice/experimental group and a representative of two independent
experiments is shown (**p < 0.01; ***p < 0.001).
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mTOR Programs HP-Induced CD8+ T Cell ResponsesmTOR activity enhances T-bet-mediated IL-15 sensitivity for
CD8+ T cell memory.
Inhibition of mTOR Promotes IL-15-Independent
CD8+ T Cell Memory
The observations made thus far suggest that HP-induced mTOR
activity promotes T-bet mediated CD8+ T cell functional matura-
tion and CD122 expression for IL-15-dependent memory. There-
fore, we predicted that along with the loss of T-bet expression
and functional maturation, mTOR blockade would abolish
HP-induced CD8+ T cell memory and provide a mechanistic
basis for the efficacy of rapamycin in BMT induced GVHD and
loss of tumor efficacy. Unexpectedly, rapamycin treatment
(day 0–7) led to a considerable increase in OT-1 cell persistence
until day 40 (Figure 5A). Unlike antigen-experienced OT-1 cells,
OT-1 cells derived from either rapamycin treated or nontreated
irradiated hosts expressed CD44int, CD62hi, IL-7Rahi, and
KLRG1lo on day 5 (Figure S5). Moreover, the OT-1 cells from
untreated and treated recipients expressed comparable pheno-
types reflective of their transition to memory precursor-like cells
in a kinetic manner, except for their expression of CD122 and
IL-7Ra (Figure S5). The early loss in CD122 expression (day 10)
was reversed by day 20 and maintained till day 40, whereas
the inhibition of mTOR enhanced the expression of IL-7Ra at
day 40 (Figure S5). When rechallenged with antigen plus incom-
plete Freund’s adjuvant (IFA), rapamycin-treated recipients did
not show a difference in the fold expansion of the OT-1 cells,
but because of greater persistence of OT-1 cell numbers, the
rapamycin-treated recipients showed enhanced memory func-
tions (Figure 5B). The memory OT-1 cells at day 40 in irradiated
recipients that were treated with or without rapamycin produced
type I effector response upon antigen rechallenge (IFN-g and546 Immunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc.in vivo CTL) (Figure 5B). This result indicates that transient
blockade of HP-induced mTOR by short duration of rapamycin
treatment leads to decreased CD8+ T cell HP, clonal expansion,
and effector functions but enhanced sustenance for memory.
Given that mTOR blockade results in reduced T-bet mediated
CD122 expression but augments memory, we reasoned that
rapamycin-mediated CD8+ T cell memory is distinct in its
requirement for IL-15. To test this idea, we monitored OT-1 cells
transferred into irradiated B6 Il15/ recipients for persistence
and antigen-recall responses with or without rapamycin treat-
ment. As shown in Figure 5C, the frequency and the absolute
numbers of OT-1 cells were decreased on day 40 in Il15/
compared to intact radiated recipients. However, rapamycin
treatment restored persistence (day 40) and antigen-recall
responses (day 43) of OT-1 cells in irradiated Il15/ recipients
(Figure 5C).
To directly confirm whether mTOR acts intrinsically in CD8+
T cells to promote HP induced memory responses, we silenced
mTOR in OT-1 cells by using a retrovirus carrying mTOR RNAi
and examined their persistence and recall responses after adop-
tive retransfer into irradiated recipients. The OT-1 cells trans-
duced with mTORRNAi constructs showed remarkable increase
in persistence (cell numbers on day 40) (Figure 5D, left panel) and
antigen-recall responses, fold increase in OT-1 cell numbers,
and increase in production of IFN-g (Figure 5D, middle and right
panels). These data establish a CD8+ T cell-intrinsic role of
mTOR in regulating HP induced memory differentiation.
Inhibition of mTOR Regulates Transcriptional Factor
Expression for CD8+ T Cell Memory Generation
The balanced expression of the master transcription factors
T-bet and Eomes determines effector versus memory functional
Immunity
mTOR Programs HP-Induced CD8+ T Cell Responsesfates in CD8+ T cells (Intlekofer et al., 2005). Moreover, we have
shown that inhibition of mTOR favors Eomes over T-bet expres-
sion for increased CD8+ T cell memory generation in antigen
stimulated CD8+ T cells (Rao et al., 2011). Based on these find-
ings, we postulated that mTOR mediated IL-15 dependent and
IL-15 independent CD8+ T cell memory is due to differential
expression patterns of T-bet and Eomes in OT-1 cells. To verify
this, we first examined the relative T-bet and Eomes protein
expression in IL-7 conditioned OT-1 cells in vitro, and as
expected IL-7 induced higher amount of T-bet than Eomes
expression (Figure 6A). Remarkably, the IL-7 conditioned OT-1
cells when treated with IL-15 failed to change the expression
of T-bet, but dramatically enhanced Eomes expression (Fig-
ure 6A). Moreover, rapamycin treatment altered HP-induced
transcriptional profile of OT-1 cells by inhibiting T-bet for
increased Eomes expression on day 5. The expression of
T-bet was restored by day 20; however, higher amount of Eomes
expression were noted in rapamycin-treated recipients (Fig-
ure 6B and Figure S6), which suggesting that HP-induced
memory requires IL-7-mTOR for T-bet expression that sensitizes
OT-1 cells for IL-15 mediated increases in Eomes expression. In
contrast, rapamycin blockade of mTOR switches T-bet for
Eomes expression without the need for extrinsic programming
by IL-15. Notably, irrespective of the pathway employed, the
relative patterns of T-bet and Eomes expression is associated
with HP-induced CD8+ T cell memory.
Collectively, the above data indicate that mTOR regulates
CD8+ T cell memory differentiation in an IL-15-dependent
and -independent manner. The ability of rapamycin treatment
to induce IL-15 independent CD8+ T cell memory was accompa-
nied by a transient decrease in endogenous CD4+ and CD8+
T cell numbers, which were rapidly resurrected (by day 20) in ra-
pamycin-treated recipients (data not shown). Thus, the reduction
in clonal expansion and functional maturation of OT-1 cells upon
rapamycin treatment was not an indirect effect of enhanced
reconstitution kinetics of endogenous T cells, although the
contributions of the myeloid compartment requires more testing.
HP Induced CD8+ T Cell Memory Has Antitumor Efficacy
Previously, it has been reported that lymphopenia can generate
CD8+ T cell mediated tumor immunity (Dummer et al., 2002). To
compare the tumor efficacy of HP-induced CD8+ T cell memory
cells produced with or without rapamycin treatment, we moni-
tored B6 mice that received EL4 (parental) or EG.7 (EL-4 cells
transfected with OVA) thymoma tumor cells on day7 and naive
OT-1 cells on day 0 for subcutaneous tumor growth and survival.
As noted, transfer of OT-1 cells into radiated recipients pro-
longed survival and reduced the size of the EG.7 tumor, but
not the EL-4 tumor burden. Importantly, rapamycin administra-
tion in radiated recipients also enhanced survival rates (p =
0.0816) and delayed EG.7 tumor growth (p = 0.0167) (Figures
7A and 7B). It is noteworthy that rapamycin alone (in the absence
of radiation) also provided some tumor protection in both s.c.
and i.p. models, suggesting its potential ability to directly affect
tumor cell growth, perhaps by regulating angiogenesis (Brown
et al., 2003; Guba et al., 2002). Therefore, demonstrating that
mTOR mediated CD8+ T cell memory induction, with or without
clonal expansion and functional maturation, is a major determi-
nant for HP-induced tumor efficacy.DISCUSSION
The generation of HP-induced CD8+ T cell memory has been
shown to require self-peptide-MHC class I interactions as well
as an abundance of the cytokines IL-7 and IL-15. Although
HP-induced CD8+ T memory cells are relatively weaker in their
protective recall responses (Cheung et al., 2009; Hamilton
et al., 2006), they are capable of empowering host immunity to
tumor and infectious challenge in vivo (Dummer et al., 2002;
Ma et al., 2003; Suzuki et al., 2008). To exploit HP-induced
CD8+ T cell memory responses for protection against infectious
diseases and cancer, we need to better understand the cell-
intrinsic pathways that guide naive CD8+ T cell differentiation
for memory in response to lymphopenia. Here, we demonstrate
that mTOR plays an essential role in regulating self-peptide-
MHC class I-, IL-7-, and IL-15-mediated gene programs that
promote HP-induced CD8+ T cell functional maturation and
memory responses. In addition, we demonstrate that mTOR
inhibition produces cell-intrinsic changes in transcriptional
programs to promote CD8+ T cell memory in an IL-15-indepen-
dent manner. Notably, HP-induced CD8+ T cell memory gener-
ated by cell-extrinsic (IL-15-dependent) or -intrinsic (mTOR
inhibition, IL-15-independent) pathways produces similar
expression patterns of transcription factors and achieves equiv-
alent tumor immunity at later time-points. This is quite surprising
given that mTOR inhibition by rapamycin augments CD8+ T cell
memory functions but dampens early CD8+ T cell clonal expan-
sion and transient effector maturation.
Our results demonstrate an essential role for IL-7-activated
mTOR in HP-induced functional maturation as reflected by
IFN-g secretion, Granzyme B, and cytolytic activity. Indeed,
several studies have previously reported that IL-7 but not IL-15
can promote survival and HP of naive CD8+ T cells (Goldrath
et al., 2002; Schluns et al., 2000; Tan et al., 2001; Tan et al.,
2002; Webb et al., 1999). Although Janus kinase 3 (Jak3) and
STAT5 dependent pathways have been implicated in Akt- and
PI3K-mediated survival and expansion of cytokine-induced
CD8+ T cells (Cantley, 2002; Pallard et al., 1999; Venkitaraman
andCowling, 1994), the precisemolecular mechanisms bywhich
IL-7 regulates CD8+ T cell functional maturation and memory
generation are not well understood. Our results indicate that lym-
phopenia-associated IL-7 abundance induces mTOR in naive
CD8+ T cells for HP. This was confirmed by our in vitro studies
in which IL-7 in a dose-dependent manner induced mTOR
activity and subsequent proliferation, clonal expansion, and
functional maturation. The fact that IL-15 was not required
in vivo and was unable to induce mTOR-dependent naive
CD8+ T cell proliferation was somewhat contradictory to recent
data showing robust proliferation and functional responses of
CD8+ T cell derived from B6 mice when treated with IL-15
(1 mg/ml) but not IL-7 (1 mg/ml) (Cho et al., 2010). These discrep-
ancies may be due in part to the dose of cytokines used and the
source of naive CD8+ T cells (non-Rag2/ background). Indeed,
by using comparable experimental settings, we have confirmed
that IL-7 at 10 ng/ml and IL-15 at 1 mg/ml can induce HP, clonal
expansion, and IFN-g production by polyclonal B6 and TCR Tg
OT-1 cells (data not shown). However, the relevance of this
in vivo is somewhat questionable given that no differences in




Figure 5. Inhibition of mTOR Promotes IL-15-Independent HP-Induced CD8+ T Cell Memory
(A–C)WT or Il15/ irradiatedOT-1 recipients that were either untreated or treatedwith rapamycin (0.75mg/kg/day) fromday 0–7were evaluated on day 40 for the
absolute numbers of OT-1 cells (A) and antigen-recall responses measured on day 43 (B). Number of OT-1 cells (left), percentage of IFN-g+ OT-1 cells (middle),
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mTOR Programs HP-Induced CD8+ T Cell ResponsesThe fact that naive CD8+ T cells express low amounts of CD122
further suggests that ‘‘high dose’’ IL-15 (1 mg/ml) would be
required for their HP response, which could be available under
certain conditions in tissue microenvironments, but was not
observed under radiation-induced lymphopenia we generated.
Therefore, we conclude that radiation-associated abundant
IL-7 induces mTOR-dependent HP, leading to CD122 expres-
sion and IL-15 responsiveness in CD8+ T cells.
In contrast to antigen-dependent differentiation, the mecha-
nisms by which HP induces CD8+ T cell memory differentiation
have not been fully characterized. Our findings are the first to
demonstrate that the IL-7-induced mTOR activity induces
T-bet expression, which is required for increased CD122 expres-
sion and integration of IL-15-mediated signals for memory tran-
sition. The role of IL-15 to mediate transition of HP-induced
effector CD8+ T cells to memory is further corroborated by the
noted increase in Eomes expression, demonstrating the ability
of mTOR to bridge IL-7- and IL-15-mediated cell-extrinsic
factors to program CD8+ T cell memory generation by regulating
transcriptional programs.
Recently, a central role for mTOR in antigen induced CD8+
T cell memory generation has been demonstrated (Araki et al.,
2009; Pearce et al., 2009; Rao et al., 2010). Therefore, it was
logical to expect that cell-intrinsic programs were important in
HP-induced CD8+ T cell memory generation, but it was not
entirely clear whether they would be sufficient. On the basis of
the in vivo use of rapamycin to regulate mature CD8+ T cell
responses (750 mg/kg/day for 8 days) (Araki et al., 2009; Phung
et al., 2007), we inhibited mTOR activity and validated the notion
that HP-induced CD8+ T cell memory can be produced without
the requirement for extrinsic factors like IL-15. The ability of
rapamycin treatment to switch T-bet for Eomes expression at
early time points (day 5), was associated with the imprinted
memory fate, which could not be reversed by subsequent
re-expression of T-bet along with persistent Eomes expression.
In congruence with the skewed pattern of T-bet and Eomes
expression in antigen induced CD8+ T cells (Intlekofer et al.,
2005; Rao et al., 2010), our findings indicate that HP-induced
mTOR activity regulates T-bet versus Eomes expression for
regulating CD8+ T cell functional fate.
Interestingly, the re-expression of T-bet at later time points
leads to CD122 expression in OT-1 cells, which is not function-
ally required, as rapamycin promotes HP-induced CD8+ T cell
memory in the absence of IL-15. This information has consider-
able value for understanding the impact of rapamycin treatment
on BMT-associated GVHD and graft versus tumor (GVT) effects,
given that it can assist in the development of new strategies to
enhance the therapeutic index of BMT in the clinic. It was also
quite intriguing that although rapamycin decreased OT-I clonal
expansion at day 5, the numbers had recuperated by day 40and in vivo cytolysis (right). In (C), the top section shows the percentage of OT-1 c
represent the OT-1 population and the numbers indicate the percent frequency
section shows the number of OT-1 cells on day 43, the percentage of IFN-g+ OT-1
parenthesis indicate the fold increase in OT-1 numbers after immunization.
(D) RNAi-mediated inhibition of mTOR promotes HP-induced CD8+memory T cell
retroviruses expressing RNAi for mTOR or empty control vector. OT-1 cells w
evaluated on day 40 post transduction and antigen-recall responses were measu
numbers after immunization (middle panel). The error bars are the SD of values o
experiments is shown (*p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant).and their ability to produce antigen-recall responses was consid-
erably better than IL-15-dependent HP-induced memory CD8+
T cells (absence of rapamycin treatment). It can be envisaged
that despite their similarity in cell-surface phenotype and
functional outcomes, the CD8+ memory T cells generated by
IL-15-dependent or -independent pathways represent distinct
subtypes of memory cells. Although only two functional types
have been described, effector memory and central memory,
this may represent an oversimplification that can be character-
ized further by detailed analysis directed at understanding the
functional attributes of rapamycin- versus nonrapamycin-gener-
ated CD8+ memory T cells.
The inherent ability of HP-induced (IL-15-dependent extrinsic)
and rapamycin-treated (IL-15-independent intrinsic) memory
CD8+ T cells to produce comparable antitumor effects indicates
that HP-induced tumor immunity is dependent on CD8+ memory
T cells, irrespective of their method of production. Additionally,
these findings lend support to the notion that the tumor efficacy
of CD8+ T cells is dependentmore onmemory than effector func-
tions or vigorous proliferation at early time points (Gattinoni et al.,
2009; Rao et al., 2010). This understanding urges reconsidera-
tion of established paradigms guiding active immune-based
therapies for cancer. Finally, the better understanding of cell-
intrinsic and -extrinsic pathways that regulate HP-induced
CD8+memory T cell generation provide new targets for exploring
means to favor GVT over GVHD.
EXPERIMENTAL PROCEDURES
Mice and Reagents
The C57BL/6 (B6) mice (National Cancer Institute-Fredrick), CD8+ TCR
transgenic mice with Thy1.1congenic marker (OT-1), and Tbx21/ OT-1
(T-bet-deficient) mice were bred and maintained in accordance with IACUC-
approved protocol at RPCI. OT-1 mice and Tbx21/ OT-1 mice were >20
generations backcrossed to recombination activating gene (Rag)-2-deficient
mice (The Jackson Laboratory). The Il15/B6 mice were purchased from
Taconic. RmIL-7 and rmIL-15 was purchased from Peprotech (Rocky Hill,
NJ). Rapamycin was purchased fromSigma Aldrich (St. Louis, MO) and Chem-
ieTek (Indianapolis, IN). The rapamycin was diluted with PBS and used at
0.75 mg/kg/day in vivo by intraperitoneal (i.p.) injection and at 20 ng/ml
in vitro. The PI3K inhibitor (LY294002) was purchased from Calbiochem,
whereas phorbol ester PMA, ionomycin, and brefeldin A were purchased
from Sigma-Aldrich.
Flow Cytometry
All mAbs used for flow cytometry were purchased from BD PharMingen,
except for anti-IL-7Ra (A7R34), anti-Eomes (Dan11mag), anti-T-bet
(eBio4B10), and anti-Granzyme B (16G6), which were purchased from
eBioscience, and anti-CD8a (53-6.7), purchased from Biolegend. The
hybridoma secreting anti-IL-7Ra (clone SB199) was kindly provided by P. Kin-
cade (University of Oklahoma). The following antibodies were purchased from
Cell Signaling: anti-mTORp (Ser 2481), anti-pS6 (Ser 235/236), and phospho-
STAT5 (pSTAT5). Intracellular staining (ICS) and flow cytometry for IFN-g,ells (CD8+ Thy1.1+) in WT or Il15/ recipients on day 40 or day 43. The circles
. The middle section shows the number of OT-1 cells on day 40. The bottom
cells, and the percentage of granzyme B+ OT-1 cells on day 43. The numbers in
s. Naive OT-1 cells activated in vivo in irradiated B6 hosts were transduced with
ere then transferred into irradiated B6 hosts. The number of OT-1 cells was
red on day 43. The numbers in parenthesis indicate the fold-increase in OT-1
btained from three animals/experimental groups and one of two independent
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Figure 6. IL-15 Regulates the Expression of T-bet and Eomes in IL-7-Conditioned CD8+ T Cells
(A) Naive OT-1 cells stimulated with IL-7 (10 ng/ml) for 72 hr were recultured with IL-15 at various concentration for additional 24 hr. The expression of T-bet and
Eomes in OT-1 cells at 72 hr (left) and 72+24 hr (middle). Numbers above the lines indicate mean fluorescence intensity (MFI). The fold increase in OT-1 cells
expressing Eomes or T-bet posttreatment of IL-15 (72+24 hr/72 hr, right). The data are representative of three independent experiments.
(B) Shown on the left, splenocytes from irradiated recipients or irradiated recipients followed the treatment of rapamycin (0.75 mg/kg/day, day 0-day 7) were
stained for T-bet and Eomes by ICS on day 5 or day 40. Numbers above the lines indicatesmean fluorescence intensity (MFI). Right, the fold-increase inOT-1 cells
expressing Eomes or T-bet (day 40/day 5). The error bars represent SD of values obtained from three animals/experimental groups. The data are representative of
two independent experiments.
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described (Rao et al., 2010). Expression of IFN-g was determined after
a 5 hr antigen restimulation. Single-cell suspensions from spleens and/or
lymph nodes were stained and analyzed by flow cytometry. Donor OT-1 cells
were detected as CD8a and Thy1.1 double positive and gated for further anal-
ysis. Flow cytometry was performed on a FACSCalibur and data analyzed with
CellQuest software (BD Biosciences).
Cell Culture, Stimulation, and Proliferation
The LN cells fromOT-1Rag2/micewere negatively selected for CD8+ T cells
(Cedarlane Lab Ltd, ON). The OT-1 cells after enrichment were >90%550 Immunity 34, 541–553, April 22, 2011 ª2011 Elsevier Inc.CD8+TCR Va+ and >95% CD44loCD122lo by flow cytometric analysis. The
OT-1 cells treated with or without rapamycin for 30 min before addition of
IL-7 were harvested at indicated time for staining and evaluation by flow
cytometry. In a few experiments, IL-7-stimulated OT-1 cells were harvested
(72 hr) and restimulated with various doses of IL-15 for an additional 24 hr
and then evaluated by flow cytometry. Proliferation was measured by the
addition of 1 mCi [3H] thymidine per well for the last 12 hr of culture.
Adoptive Transfer and IL-7 Blockade
Lymphopenia was induced in naive age- and sex-matched B6 recipient mice
by radiation (0, 175, or 700 rads) and the mice were maintained on antibiotics
A B
Figure 7. mTOR Inhibitor Enhances HP-Mediated Tumor Protection
(A and B) B6mice inoculated with 33 106 EL4 or EG.7 by i.p. or s.c. injection on day7 were irradiated (700 rad) on day2 and received 13 106 naive OT-1 cells
on day 0. Rapamycin was injected into indicated recipients from day 0 - 7 post-transfer. (A) Tumor-free survival curve. (B) Tumor size (mean ± s.e.m.) curve.
Data in this figure were pooled from three independent experiments.
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with 5 mM CFSE (Invitrogen) were (i.v.) adoptively transferred into syngeneic
recipients (2 days after radiation) as described (Kieper et al., 2001). Intact
mice were also given immunization by s.c. injection of recombinant poxvirus
expresses chicken ovalbumin on day 0 (immunization). In some experiments,
the purified anti-IL-7Ra (100 mg per mouse twice a week) was injected so that
IL-7 blockade in vivo could be achieved.
Evaluation of In Vivo OT-1 Cell Responses
The total number of adoptively transferred OT-1 cells (CD8a+Thy1.1+) in recip-
ient mice was determined by multiplying the total cell counts into the
percentage of CD8a+Thy1.1+ T cells detected by flow cytometry at the indi-
cated time points. The in vivo CTL assays were performed after normalizing
OT-1 cell numbers and retransfer into intact target bearing mice as previously
described (Nelson et al., 2000).
Plasmid and Retrovirus-Based RNAi
The pMKO.1 GFP retroviral vector (plasmid 10676) was obtained from Addg-
ene (Cambridge, MA). The pMKO.1 GFP retroviral vector encoding RNAi for
mTOR was a kind gift of R. Ahmed (Emory University, Atlanta, GA) (Araki
et al., 2009). The pMKO.1 or its derivative was transfected into a viral pack-
aging cell line along with the plasmid pCL-Eco. Naive OT-1 (Thy1.1+) cells
adoptively transferred into 700 rad irradiated mice were isolated by anti-
CD90.1 MicroBeads on a MiniMACS Separator (Miltenyi Biotec) on day 5
and subsequently spin-transduced at 30C for 2 hr with freshly collected retro-
virus. The OT1 cells were sorted for GFP+ cells (1 3 106) and were adoptively
transferred into 700 rad irradiated B6 recipients 3 days after transduction
(matched for radiation treatment). The persistence of OT-1 cells and
antigen-recall response was evaluated on days 40 and 43.
In Vivo Tumor Challenge
B6 mice inoculated with EL4 thymoma or EG.7-OVA thymoma (3 3 106 cells
per mouse) by s.c. or i.p. injection on day 7, were radiated (700 rad) on
day 2 and naive OT-1 cells (1 3 106 per mouse) adoptively transferred on
day 0. Rapamycin (0.75 mg/kg/day) was injected into indicated recipients
(i.p.) every day between day 0 7 after OT-1 cell transfer. Tumor volume
were calculated by measuring diameters of the tumor in the X and Y plane
with digital calipers and entering measurements into the equation tumor
volume tumor volume (mm3) = (major axis) 3 (minor axis)2 3 0.52.Statistical Analysis
The unpaired student’s t test was applied with GraphPad Prism software to all
data points. Tumor survival between various groups was compared with
Kaplan Meier survival curves and log-rank statistics. Significance is indicated
as follows: * p < 0.05; ** p < 0.01; and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.immuni.2011.04.006.
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